首页> 外文OA文献 >Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

【2h】

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

机译：Mirogabalin（DS-5565）治疗糖尿病外周神经病疼痛的疗效和安全性：随机，双盲，安慰剂和活跃的比较，适应性概念阶段2研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Aaron Vinik; Julio Rosenstock; Uma Sharma; Karen Feins; Ching Hsu; Domenico Merante;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study [J] . Vinik,A., Rosenstock,J., Sharma,U., Diabetes care . 2014,第12期

机译：米罗巴林（DS-5565）用于治疗糖尿病性周围神经性疼痛的功效和安全性：一项随机，双盲，安慰剂和活性比较剂控制的自适应概念验证的2期研究
2. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study [J] . Merante Domenico, Rosenstock Julio, Sharma Uma, Pain medicine : . 2017,第11期

机译：Mirogabalin（DS-5565）对患者报告的患者患者患者患者患者的疗效和睡眠干扰：II期概念证据研究的二次结果
3. Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study [J] . Masayuki Baba, Masanori Kuroha, Shoichi Ohwada, Pain and therapy. . 2020,第1期

机译：亚洲科目糖尿病外周神经病疼痛的Mirogabalin治疗结果：2阶段，双盲，随机，安慰剂控制，研究
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Body schema acuity training and FeldenkraisRTM movements compared to core stabilization biofeedback and motor control exercises: Comparative effects on chronic non-specific low back pain in an outpatient clinical setting: A randomized controlled comparative efficacy study. [D] . Sobie, Timothy J. 2016

机译：与核心稳定生物反馈和运动控制练习相比，身体模式敏锐度训练和FeldenkraisRTM运动：在门诊临床环境中对慢性非特异性下背痛的比较效果：一项随机对照比较功效研究。
6. Results of Mirogabalin Treatment for Diabetic Peripheral Neuropathic Pain in Asian Subjects: A Phase 2 Double-Blind Randomized Placebo-Controlled Study [O] . Masayuki Baba, Masanori Kuroha, Shoichi Ohwada, 2020

机译：Mirogabalin治疗亚洲受试者糖尿病性周围神经性疼痛的结果：2期双盲随机安慰剂对照研究
7. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study [O] . Domenico Merante, Julio Rosenstock, Uma Sharma, 2017

机译：Mirogabalin（DS-5565）对患者报告的患者患者患者患者的患者患者的疗效和睡眠干扰：II期概念证据研究的二次结果

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

著录项

引文网络

相似文献

相关主题

期刊订阅